We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$11.4B
AUM Growth
+$466M
Cap. Flow
-$346M
Cap. Flow %
-3.04%
Top 10 Hldgs %
11.96%
Holding
2,051
New
157
Increased
773
Reduced
962
Closed
143

Sector Composition

Rank Sector Weight
1 Technology 16.57%
2 Healthcare 11.82%
3 Financials 9.9%
4 Industrials 8.01%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMC icon
1826
United Microelectronic
UMC
$46.9B
$172K ﹤0.01%
26,350
-39,714
-60% -$263K
CPAAW
1827
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$171K ﹤0.01%
1,150,862
-2,100
-0.2% -$305
STLA icon
1828
Stellantis
STLA
$20.8B
$167K ﹤0.01%
11,786
-5,388
-31% -$75K
ZIMV
1829
DELISTED
ZimVie
ZIMV
$166K ﹤0.01%
+17,824
New +$156K
ERC
1830
Allspring Multi-Sector Income Fund
ERC
$259M
$166K ﹤0.01%
16,980
-62
-0.4% -$574
JRS icon
1831
Nuveen Real Estate Income Fund
JRS
$246M
$166K ﹤0.01%
22,006
-258
-1% -$2.02K
BLNK icon
1832
Blink Charging
BLNK
$87.9M
$163K ﹤0.01%
14,814
+4,539
+44% +$61.9K
AMCX icon
1833
AMC Global Media
AMCX
$489M
$161K ﹤0.01%
+10,299
New +$204K
CARS icon
1834
Cars.com
CARS
$689M
$159K ﹤0.01%
+11,546
New +$156K
IFN
1835
Aberdeen India Fund
IFN
$504M
$155K ﹤0.01%
10,436
-122
-1% -$1.96K
CCU icon
1836
Compañía de Cervecerías Unidas
CCU
$2.21B
$154K ﹤0.01%
+11,706
New +$135K
HQL
1837
abrdn Life Sciences Investors
HQL
$627M
$153K ﹤0.01%
+10,734
New +$156K
ARQT icon
1838
Arcutis Biotherapeutics
ARQT
$3.18B
$152K ﹤0.01%
10,297
-1,598
-13% -$27.9K
MPAA icon
1839
Motorcar Parts of America
MPAA
$258M
$152K ﹤0.01%
+12,806
New +$186K
DOUG icon
1840
Douglas Elliman
DOUG
$162M
$150K ﹤0.01%
+38,782
New +$155K
EMF
1841
Templeton Emerging Markets Fund
EMF
$326M
$150K ﹤0.01%
13,139
-136
-1% -$1.53K
SSP icon
1842
E.W. Scripps
SSP
$304M
$149K ﹤0.01%
+11,323
New +$156K
BHC icon
1843
Bausch Health
BHC
$2.34B
$148K ﹤0.01%
23,553
+6,630
+39% +$46.3K
WWW icon
1844
Wolverine World Wide
WWW
$1.55B
$145K ﹤0.01%
+13,289
New +$177K
XRN
1845
Chiron Real Estate Inc
XRN
$477M
$145K ﹤0.01%
3,060
+484
+19% +$21.9K
OYST
1846
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$143K ﹤0.01%
+12,816
New +$124K
OIS icon
1847
Oil States International
OIS
$491M
$142K ﹤0.01%
19,068
+2,455
+15% +$15.2K
FIRY
1848
Firy Inc
FIRY
$163M
$142K ﹤0.01%
13,924
-2,163
-13% -$39.8K
GNT
1849
GAMCO Natural Resources, Gold & Income Trust
GNT
$144M
$138K ﹤0.01%
26,891
-350
-1% -$1.65K
SBH icon
1850
Sally Beauty Holdings
SBH
$1.58B
$137K ﹤0.01%
+10,926
New +$134K

Similar funds

Guggenheim Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Guggenheim Capital held 2,051 positions worth $11.4B, up 4.3% from $10.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Guggenheim Capital withdrew a net $346M in Q4 2022, closing 143 positions and reducing 962 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Guggenheim Capital opened a new position in Guggenheim Active Allocation Fund worth $4.25M.

  • Guggenheim Capital's largest Q4 2022 buy was Guggenheim Active Allocation Fund: 315,680 shares worth $4.25M.
  • Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $43.4M increase.
  • Guggenheim Capital's biggest Q4 2022 reduction was Apple, cutting an estimated $22.7M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $109M.
  • Guggenheim Capital's ten largest holdings make up 12% of its $11.4B portfolio in Q4 2022.
  • Guggenheim Capital opened 157 new positions and closed 143 in Q4 2022.
  • Guggenheim Capital's portfolio value rose 4.3% quarter-over-quarter to $11.4B.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.